JP2024515830A5 - - Google Patents
Info
- Publication number
- JP2024515830A5 JP2024515830A5 JP2023566515A JP2023566515A JP2024515830A5 JP 2024515830 A5 JP2024515830 A5 JP 2024515830A5 JP 2023566515 A JP2023566515 A JP 2023566515A JP 2023566515 A JP2023566515 A JP 2023566515A JP 2024515830 A5 JP2024515830 A5 JP 2024515830A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- degrees
- dose
- subject
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163181807P | 2021-04-29 | 2021-04-29 | |
| US63/181,807 | 2021-04-29 | ||
| PCT/US2022/026908 WO2022232494A1 (en) | 2021-04-29 | 2022-04-29 | Neuroactive steroid for use in treating major depressive disorder and postpartum depression in a lactating female |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515830A JP2024515830A (ja) | 2024-04-10 |
| JP2024515830A5 true JP2024515830A5 (cg-RX-API-DMAC7.html) | 2025-05-09 |
Family
ID=81748326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023566515A Pending JP2024515830A (ja) | 2021-04-29 | 2022-04-29 | 母乳を出している女性における大うつ病性障害および産後うつ病の処置における使用のための神経活性ステロイド |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240216396A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4329769A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024515830A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117580580A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022267304A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3217866A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL307980A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023012728A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022232494A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS62761B1 (sr) | 2012-08-21 | 2022-01-31 | Sage Therapeutics Inc | Alopregnanolon za lečenje refraktornog epileptičkog statusa |
| SMT202100509T1 (it) | 2013-04-17 | 2021-11-12 | Sage Therapeutics Inc | Steroide di c21-n-pirazolile 19-nor c3,3-disostituito per l'uso in terapia |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| JOP20200195A1 (ar) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | سترويدات وتركيبات نشطة عصبياً، واستخداماتها |
| WO2016082789A1 (en) | 2014-11-27 | 2016-06-02 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| WO2018013613A1 (en) | 2016-07-11 | 2018-01-18 | Sage Therapeutics, Inc. | C17, c20, and c21 substituted neuroactive steroids and their methods of use |
| TW202604538A (zh) | 2016-08-23 | 2026-02-01 | 美商賽吉醫療公司 | 結晶19-去甲c3,3-二取代之c21-n-吡唑類固醇 |
| US20200291059A1 (en) | 2017-12-08 | 2020-09-17 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SMT202100509T1 (it) | 2013-04-17 | 2021-11-12 | Sage Therapeutics Inc | Steroide di c21-n-pirazolile 19-nor c3,3-disostituito per l'uso in terapia |
| TW202604538A (zh) | 2016-08-23 | 2026-02-01 | 美商賽吉醫療公司 | 結晶19-去甲c3,3-二取代之c21-n-吡唑類固醇 |
| EP3678670A1 (en) * | 2017-09-07 | 2020-07-15 | Sage Therapeutics, Inc. | Neuroactive steroids and their methods of use |
| WO2019241442A1 (en) * | 2018-06-12 | 2019-12-19 | Sage Therapeutics, Inc. | A 19-nor c3,3-disubstituted c21 -n-pyrazolyl steroid and methods of use thereof |
| JP2022514510A (ja) * | 2018-12-14 | 2022-02-14 | プラクシス プレシジョン メディスンズ,インコーポレイテッド | うつ病の治療方法 |
| CA3187178A1 (en) | 2020-07-20 | 2022-01-27 | Sage Therapeutics, Inc. | Formulations of 19-nor c3,3- disubstituted c21-n-pyrazolyl steroid and methods of use thereof |
-
2022
- 2022-04-29 MX MX2023012728A patent/MX2023012728A/es unknown
- 2022-04-29 EP EP22724194.0A patent/EP4329769A1/en active Pending
- 2022-04-29 AU AU2022267304A patent/AU2022267304A1/en active Pending
- 2022-04-29 CA CA3217866A patent/CA3217866A1/en active Pending
- 2022-04-29 IL IL307980A patent/IL307980A/en unknown
- 2022-04-29 JP JP2023566515A patent/JP2024515830A/ja active Pending
- 2022-04-29 WO PCT/US2022/026908 patent/WO2022232494A1/en not_active Ceased
- 2022-04-29 CN CN202280045723.6A patent/CN117580580A/zh active Pending
- 2022-04-29 US US18/557,705 patent/US20240216396A1/en active Pending